Disease Group | Disease | Sample size | Fluid Source | Additional miRNA biomarkers | Predictive or Prognostic | Citation |
---|---|---|---|---|---|---|
Cardiovascular Diseases | ||||||
1 | Myocardial infarction | 272 | Plasma | miR-1, miR-499, miR-423, miR133a | Predictive | [32] |
1 | Myocardial infarction | 66 | Plasma | -- | Predictive | [33] |
2 | Coronary artery disease | 52 | Plasma | miR-23a, miR-34a | Predictive | [34] |
2 | Coronary artery disease | 147 | Plasma | miR-133b | Predictive | [35] |
3 | Acute coronary syndrome | 62 | Plasma and PBMC | miR-146, miR-155 | Predictive | [36] |
4 | Chronic cardiovascular disease | 60 | Peripheral blood | miR-92a, miR-222, miR-130a | Predictive | [37] |
5 | Left ventricular fibrosis in aortic stenosis | 132 | Plasma | -- | Prognostic | [38] |
6 | Cardiac arrest | 28 | Plasma | miR-122 | Prognostic | [39] |
Non-cardiovascular Diseases | ||||||
7 | Crohn Disease | 78 | Serum | miR-16, miR-484, miR-30e, miR-140, miR-192, miR-93, let-7b, miR-195, miR-106a, miR-20a | Predictive | [40] |
8 | Dengue Fever | 6DC / 72VC | Serum | miR-146a | Predictive | [41] |
9 | Hepatitis C | 72 | Serum | miR-27a, miR-106, miR-122, miR93, miR-199, miR-23b | Predictive and prognostic | [42] |
9 | Hepatitis C | 110 | Serum | -- | Prognostic | [43] |
10 | Multiple sclerosis | 48 | PBMC | miR-146a, miR-146b | Predictive | [44] |
11 | Non-alcoholic fatty liver | 403 | Serum | miR-34a, miR-122, miR-145, miR-451 | Predictive | [45] |
12 | Pneumonia | 176 | Serum | miR-155, miR-197, miR-182 | Predictive | [46] |
13 | Pulmonary fibrosis | 62 | Serum EV | -- | Prognostic | [47] |
13 | Pulmonary fibrosis | 130 | Serum | miR-155 | Predictive | [48] |
14 | Renal fibrosis | 42 | Serum | -- | Predictive | [49] |
15 | Systemic lupus erythematosus | 145 | Plasma | miR-126 | Predictive | [50] |
15 | Systemic lupus erythematosus | 85 | PBMC | miR-155 | Predictive | [51] |
16 | Type 2 diabetes complications | 300 DC / 40 VC | Plasma / CAC | miR-126 | Prognostic | [52] |